Interaction of nystatin with nystatin-resistant Candida tropicalis
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
6873771
DOI
10.1007/bf02884078
Knihovny.cz E-zdroje
- MeSH
- aktivní transport účinky léků MeSH
- antibiotická rezistence MeSH
- buněčná membrána metabolismus MeSH
- Candida účinky léků genetika metabolismus MeSH
- energetický metabolismus účinky léků MeSH
- ergosterol metabolismus MeSH
- membránové lipidy metabolismus MeSH
- nystatin metabolismus farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- ergosterol MeSH
- membránové lipidy MeSH
- nystatin MeSH
Nystatin-resistant yeast Candida tropicalis was obtained after UV illumination and plating on nystatin-containing media. The mutant contained no ergosterol in the plasma membrane but bound nystatin to a degree similar to that of the wild strain (1.2 vs. 1.5 nmol per mg dry solid). Respiration of the mutant on glucose was reduced by 36% in the presence of 25 microM nystatin. This corresponded to a 25-43% decrease of the uptake of monosaccharides. Transport of amino acids was reduced by nystatin in the mutant by 44-86%, as compared with a 84-95% reduction in the wild strain. The intracellular ATP content was reduced by nystatin equally in the wild strain and in the mutant (by 43 and 47%). Nystatin appears to affect specifically membrane transport processes of nonelectrolytes while both the H+-extruding ATPase and the membrane potential are unaffected.
Zobrazit více v PubMed
Microbios. 1981;30(121-122):139-51 PubMed
FEBS Lett. 1978 Jul 15;91(2):198-201 PubMed
Z Klin Chem Klin Biochem. 1967 Nov;5(6):299-304 PubMed
Biochim Biophys Acta. 1971 Aug 13;241(2):310-30 PubMed
Biochim Biophys Acta. 1981 Apr 22;643(1):265-8 PubMed
Biochim Biophys Acta. 1981 Dec 30;639(3-4):197-223 PubMed
Microbios. 1981;31(123):7-16 PubMed
Antifungal agents as tools in experimental mycology